News
Scholar Rock said on Wednesday a combination of its experimental drug and Eli Lilly's weight-loss treatment Zepbound helped overweight patients preserve significantly more lean mass in a mid-stage ...
(Reuters) -Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss that can ...
Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...
DNA firm 23andMe fined £2.31m by UK regulator for a 2023 data breach that exposed sensitive health and family information. Sale to TTAM Research to include stricter privacy commitments.
Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug ...
Genetic testing firm 23andMe has been fined £2.31 million by the UK's data protection watchdog for "serious security failings ...
This was the stock's second consecutive day of losses.
Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...
The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...
Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer protections ultimately led the board’s special committee to select it as ...
The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key ...
In a recent investigation we took a hard look at the cybersecurity practices of major direct-to-consumer DNA testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results